Is magnesium sulfate prophylaxis really necessary in patients with severe preeclampsia?

Journal of Maternal-Fetal Investigation

Volumn 6, Issue 1, 1996, Pages 14-18

  Odendaal, H J ^a   Hall, D R ^a  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Eclampsia; Magnesium sulfate; Preeclampsia

Indexed keywords

ANTICONVULSIVE AGENT; CREATININE; MAGNESIUM SULFATE; UREA; URIC ACID;

ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; CREATININE CLEARANCE; DELIVERY; DISEASE SEVERITY; DRUG EFFICACY; ECLAMPSIA; FEMALE; FETUS DISTRESS; FETUS OUTCOME; GESTATIONAL AGE; HEMATOCRIT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; PROPHYLAXIS; UREA BLOOD LEVEL;

EID: 0029870077     PISSN: 09396322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Repke JT, Friedman SA, Kaplan PW. Prophylaxis of eclamptic seizures: current controversies. Clin Obstet Gynaecol 1992;35:365-74.
2. Reti LL, Ross A, Kloss M, Paul J, Markman L. The management of severe preeclampsia with intravenous magnesium sulfate, hydralazine and central venous catheterization. Aust NZ J Obstet Gynaecol 1097 ;27:102-05.
3. Pritchard JA, Pritchard SA. Standardised treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol, 1975;123:543-52.
4. Dommisse J. Phenytoin sodium and magnesium sulfate in the management of eclampsia. Br J Obstet Gynaecol 1990;97:104-09.
5. Pritchard J. The use of magnesium sulfate in preeclampsia-eclampsia. J Reprod Med 1979;23:107-13.
6. Lipsitz PJ. The clinical and biochemical effects of excess magnesium in the newborn. Pediatrics 1971;47:501-09.
7. Odendaal HJ, Steyn DW, Norman K, Kirsten GF, Smith J, Theron GB. Improved perinatal mortality rates in 1001 patients with severe preeclampsia by expectant management. S Afr Med J 1995;85:1071-76.
8. Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol 1984; 148:951-63.
9. Odendaal HJ, Pattinson RC, Du Toit R. Fetal and neonatal outcome in patients with severe preeclampsia delivered before 34 weeks. S Afr Med J 1987;71:555-58.
10. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJvW. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990;76:1070-75.
11. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892-98.
12. Odendaal HJ, Pattinson RC, Du Toit R, Grove D. Frequent fetal heart rate monitoring for early detection of abruptio placentae in severe proteinuric hypertension. S Afr Med J 1988;74:19-21.
13. Saftlas AF, Oison DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990; 163:460-65.